pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
368
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
AP-001
Metavert
Pancreatic Cancer
Avenzoar Pharmaceuticals Inc
0
catalysts
Preclinical
APIRx-1701
Glaucoma
$IXHL
Incannex Healthcare Inc.
0
catalysts
Preclinical
APIRx-1702
Keratoconjunctivitis Sicca (Dry Eye)
$IXHL
Incannex Healthcare Inc.
0
catalysts
Preclinical
← prev
page 4 of 13
next →
131
Pain
89
Neurology
1
APP-13002
Bacterial Conjunctivitis
Formosa Pharmaceuticals Inc
0
catalysts
Phase 2
ASP-7316
Juvenile Macular Degeneration (Stargardt Disease)
Astellas Pharma Inc
0
catalysts
Phase 2
ATSN-101
Leber Congenital Amaurosis (LCA)
Atsena Therapeutics Inc
0
catalysts
Phase 3
ATSN-201
Unspecified Ophthalmological Disorders
Atsena Therapeutics Inc
0
catalysts
Phase 3
AVD-104
Dry (Atrophic) Macular Degeneration
Aviceda Therapeutics Inc
0
catalysts
Phase 3
BRM-421
Keratoconjunctivitis Sicca (Dry Eye)
BRIM Biotechnology Inc
0
catalysts
Phase 2
BRM-424
Neurotrophic Keratitis
BRIM Biotechnology Inc
0
catalysts
Phase 2
BS-01
Retinitis Pigmentosa (Retinitis)
Beacon Therapeutics Ltd
0
catalysts
Preclinical
BVA-202
Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy)
Biovista Inc
0
catalysts
Preclinical
BVA-203
Friedreich Ataxia
Biovista Inc
0
catalysts
Marketed
Betimol
Betimol (timolol maleate)
Ocular Hypertension
Thea Pharma Inc
0
catalysts
Phase 2
CAM-101
Elate Ocular
Keratoconjunctivitis Sicca (Dry Eye)
Cambium Bio Limited
0
catalysts
Preclinical
CAP-4196
Cataract
Plex Pharmaceuticals Inc
0
catalysts
Preclinical
CBS-101
Retinitis Pigmentosa (Retinitis)
CIRC Biosciences Inc
0
catalysts
Phase 2
CBT-004
Unspecified Ophthalmological Disorders
Cloudbreak Therapeutics LLC
0
catalysts
Phase 2
CBT-006
Keratoconjunctivitis Sicca (Dry Eye)
Cloudbreak Therapeutics LLC
0
catalysts
Preclinical
CBT-007
Glaucoma
Cloudbreak Therapeutics LLC
0
catalysts
Preclinical
CBT-145
Presbyopia
Cloudbreak Therapeutics LLC
0
catalysts
Preclinical
CDX-301
Juvenile Macular Degeneration (Stargardt Disease)
Cardax Inc
0
catalysts
Phase 1
CG-P5 peptide
Wet (Neovascular / Exudative) Macular Degeneration
Caregen Co Ltd
0
catalysts
Preclinical
CRG-01
Diabetic Retinopathy
CdmoGen Co Ltd
0
catalysts
Preclinical
CRG-02
Wet (Neovascular / Exudative) Macular Degeneration
CdmoGen Co Ltd
0
catalysts
Phase 2
CSB-001
Neurotrophic Keratitis
Claris Biotherapeutics Inc
0
catalysts
Preclinical
CTR-107
Noregen
Diabetic Retinopathy
Caeregen Therapeutics LLC
0
catalysts
Phase 2
CTx-001
Geographic Atrophy
B-cell lymphoma/leukemia 11A
Complement Therapeutics Ltd
0
catalysts
Phase 2
CTxPDE-6b
Retinitis Pigmentosa (Retinitis)
Coave Therapeutics
0
catalysts
Phase 2
DF-003
Chronic Kidney Disease (Chronic Renal Failure)
Drug Farm Inc
0
catalysts
